Literature DB >> 21938455

Structural insights into human GPCR protein OA1: a computational perspective.

Anirban Ghosh1, Uddhavesh Sonavane, Sai Krishna Andhirka, Gopala Krishna Aradhyam, Rajendra Joshi.   

Abstract

Human ocular albinism type 1 protein (OA1)-a member of the G-protein coupled receptor (GPCR) superfamily-is an integral membrane glycoprotein expressed exclusively by intracellular organelles known as melanocytes, and is responsible for the proper biogenesis of melanosomes. Mutations in the Oa1 gene are responsible for the disease ocular albinism. Despite its clinical importance, there is a lack of in-depth understanding of its structure and mechanism of activation due to the absence of a crystal structure. In the present study, homology modeling was applied to predicting OA1 structure following thorough sequence analysis and secondary structure predictions. The predicted model had the signature residues and motifs expected of GPCRs, and was used for carrying out molecular docking studies with an endogenous ligand, L-DOPA and an antagonist, dopamine; the results agreed quite well with the available experimental data. Finally, three sets of explicit molecular dynamics simulations were carried out in lipid bilayer, the results of which not only confirmed the stability of the predicted model, but also helped witness some differences in structural features such as rotamer toggle switch, helical tilts and hydrogen bonding pattern that helped distinguish between the agonist- and antagonist-bound receptor forms. In place of the typical "D/ERY"-motif-mediated "ionic lock", a hydrogen bond mediated by the "DAY" motif was observed that could be used to distinguish the agonist and antagonist bound forms of OA1. In the absence of a crystal structure, this study helped to shed some light on the structural features of OA1, and its behavior in the presence of an agonist and an antagonist, which might be helpful in the future drug discovery process for ocular albinism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21938455     DOI: 10.1007/s00894-011-1228-8

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  75 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

Review 2.  G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin.

Authors:  J Ballesteros; K Palczewski
Journal:  Curr Opin Drug Discov Devel       Date:  2001-09

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

4.  Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics.

Authors:  Tod D Romo; Alan Grossfield; Michael C Pitman
Journal:  Biophys J       Date:  2010-01-06       Impact factor: 4.033

5.  Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor.

Authors:  Hamiyet Unal; Rajaganapathi Jagannathan; Manjunatha B Bhat; Sadashiva S Karnik
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

6.  The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1998.

Authors:  A Bairoch; R Apweiler
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

7.  Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding.

Authors:  Karuppiah Kanagarajadurai; Manoharan Malini; Aditi Bhattacharya; Mitradas M Panicker; Ramanathan Sowdhamini
Journal:  Mol Biosyst       Date:  2009-09-08

8.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

Review 9.  New G-protein-coupled receptor crystal structures: insights and limitations.

Authors:  Brian Kobilka; Gebhard F X Schertler
Journal:  Trends Pharmacol Sci       Date:  2008-01-14       Impact factor: 14.819

10.  The ocular albinism type 1 protein, an intracellular G protein-coupled receptor, regulates melanosome transport in pigment cells.

Authors:  Ilaria Palmisano; Paola Bagnato; Angela Palmigiano; Giulio Innamorati; Giuseppe Rotondo; Domenico Altimare; Consuelo Venturi; Elena V Sviderskaya; Rosanna Piccirillo; Massimiliano Coppola; Valeria Marigo; Barbara Incerti; Andrea Ballabio; Enrico M Surace; Carlo Tacchetti; Dorothy C Bennett; Maria Vittoria Schiaffino
Journal:  Hum Mol Genet       Date:  2008-08-12       Impact factor: 6.150

View more
  2 in total

Review 1.  l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease.

Authors:  Yoshio Goshima; Daiki Masukawa; Yuka Kasahara; Tatsuo Hashimoto; Aderemi Caleb Aladeokin
Journal:  Front Pharmacol       Date:  2019-10-03       Impact factor: 5.810

Review 2.  The Many Faces of G Protein-Coupled Receptor 143, an Atypical Intracellular Receptor.

Authors:  Beatriz Bueschbell; Prashiela Manga; Anke C Schiedel
Journal:  Front Mol Biosci       Date:  2022-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.